The article, published in the Journal of Hospital Medicine, found that large urban hospitals that serve as a safety net for patients with lower socioeconomic status, are at a disadvantage due to factors outside of their control.
Mandatory patient satisfaction surveys are one of the measures introduced by the Affordable Care Act to move away from the fee-for-service to a value-based healthcare system. CMS uses patient satisfaction scores to determine reimbursement levels to hospitals.
A team of researchers at Mount Sinai Health System, evaluated survey results from 3907 hospitals across the country and found that large health systems that serve population-dense urban regions with a patient population of lower socioeconomic status, fare worse on these surveys. The authors evaluated the data to identify statistical links between patients’ perceptions of their care and demographic factors outside the control of individual hospitals.
Two variables that had a high impact on the scores were hospital size and English as a second language. The authors went ahead and developed an adjustment formula to account for the inequities in the scores. “When this adjustment formula was applied to all New York State Hospitals, three large, urban academic medical centers — NY Presbyterian, Montefiore and Mount Sinai – moved into the top 10 in ranking,” according to one of the study authors. The article has been published in The Journal of Hospital Medicine.
Read the article on newswise: http://bit.ly/1HuSpl3
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More